Bradley S. Galer
2018
In 2018, Bradley S. Galer earned a total compensation of $2.6M as Executive Vice President and Chief Medical Officer at Zogenix, a 153% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $178,300 |
|---|---|
| Option Awards | $1,700,357 |
| Salary | $409,648 |
| Stock Awards | $266,563 |
| Total | $2,554,868 |
Galer received $1.7M in option awards, accounting for 67% of the total pay in 2018.
Galer also received $178.3K in non-equity incentive plan, $409.6K in salary and $266.6K in stock awards.
Rankings
In 2018, Bradley S. Galer's compensation ranked 4,573rd out of 14,244 executives tracked by ExecPay. In other words, Galer earned more than 67.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,573 out of 14,244 | 68th |
Division Manufacturing | 1,714 out of 5,765 | 70th |
Major group Chemicals And Allied Products | 618 out of 2,128 | 71st |
Industry group Drugs | 517 out of 1,817 | 72nd |
Industry Pharmaceutical Preparations | 400 out of 1,391 | 71st |
Source: SEC filing on April 9, 2019.
Galer's colleagues
We found four more compensation records of executives who worked with Bradley S. Galer at Zogenix in 2018.